VitalRx
    Physician-Supervised Peptide Therapy · All 50 StatesSee Peptides
    Growth Hormone Optimization

    CJC-1295 / Ipamorelin
    Smarter Growth Hormone Optimization

    The most widely used growth hormone secretagogue combination in clinical practice, because it works with your body's natural GH rhythm instead of overriding it.

    CJC-1295 and Ipamorelin are two peptides that work through complementary mechanisms to amplify your body's own growth hormone output, producing a sustained, physiologically appropriate pulse rather than the blunt spike of exogenous GH. The result: improved body composition, faster recovery, deeper sleep, and meaningful anti-aging benefits, without suppressing your natural hormone axis. Available at VitalRx as a prescription-only injectable, reviewed by a licensed provider and compounded by Optimal Balance Pharmacy. Your async consult is included.

    View Pricing

    Prescription required. Async provider visit included with your order.

    Licensed Physicians
    Prescription Required
    Licensed U.S. Pharmacy
    FedEx Overnight Shipping

    Published March 1, 2026

    What Is CJC-1295 / Ipamorelin?

    CJC-1295 / Ipamorelin is a compounded blend of two distinct growth hormone secretagogue peptides, CJC-1295 (a GHRH analogue) and Ipamorelin (a GHRP), that work through separate but synergistic pathways to stimulate the pituitary gland's natural growth hormone release.

    CJC-1295 is a modified analogue of Growth Hormone Releasing Hormone (GHRH), the signal the hypothalamus uses to tell the pituitary to produce and release growth hormone. By mimicking and extending this signal, CJC-1295 amplifies the baseline growth hormone pulse, producing a broader and more sustained elevation of GH levels. The DAC (Drug Affinity Complex) version binds to albumin in the bloodstream, extending its half-life to several days and providing continuous background GHRH stimulation.

    Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP); it binds to ghrelin receptors in the pituitary and hypothalamus, triggering a clean, selective GH pulse. Unlike older GHRPs such as GHRP-2 and GHRP-6, Ipamorelin does not significantly elevate cortisol, prolactin, or appetite, making it the most side-effect-favorable GHRP available.

    Together, CJC-1295 and Ipamorelin create a synergistic effect that is substantially greater than either peptide alone. CJC-1295 sets the hormonal stage by elevating baseline GH output; Ipamorelin then triggers a well-timed, amplified GH pulse on top of that elevated baseline. The result is a meaningful and sustained increase in growth hormone and downstream IGF-1, the combination most commonly prescribed for body composition, recovery, sleep quality, and age-related GH decline.

    How CJC-1295 / Ipamorelin Works

    Understanding why CJC-1295 and Ipamorelin are almost always prescribed together requires understanding the two distinct pathways through which the body naturally controls growth hormone release.

    The pituitary gland releases growth hormone in response to two primary signals: GHRH from the hypothalamus (which triggers release) and ghrelin receptor activation (which amplifies it). CJC-1295 works on the first pathway, acting as a long-acting GHRH analogue that continuously primes the pituitary for GH release. Ipamorelin works on the second, triggering a selective, clean GH pulse through ghrelin receptor activation.

    By stimulating both pathways simultaneously, the combination produces a GH pulse that is significantly larger than either peptide generates alone, while still remaining within the body's natural physiological rhythm. This is the critical distinction from exogenous human growth hormone: CJC-1295 / Ipamorelin amplifies your own GH axis rather than replacing it, preserving natural feedback regulation and avoiding the suppression of endogenous production that comes with synthetic HGH.

    Key Biological Pathways

    CJC-1295: GHRH Receptor Agonism

    CJC-1295 binds to GHRH receptors in the pituitary, mimicking and extending the hypothalamus's natural growth hormone releasing signal to produce a sustained elevation in baseline GH output.

    CJC-1295: Extended Half-Life via DAC

    The DAC modification allows CJC-1295 to bind to albumin in the bloodstream, extending its half-life from minutes to several days and providing continuous GHRH stimulation between injections.

    Ipamorelin: Selective Ghrelin Receptor Activation

    Ipamorelin binds to ghrelin receptors (GHS-R1a) in the pituitary and hypothalamus, triggering a targeted GH pulse without the cortisol, prolactin, or appetite side effects of older GHRPs.

    Synergistic GH Amplification

    The combination of GHRH agonism (CJC-1295) and ghrelin receptor activation (Ipamorelin) produces a GH pulse substantially larger than either peptide generates independently, while staying within physiological ranges.

    IGF-1 Upregulation

    Elevated growth hormone drives increased hepatic production of IGF-1 (Insulin-like Growth Factor 1), the downstream mediator responsible for many of GH's anabolic, recovery, and anti-aging effects on muscle, bone, and connective tissue.

    Preservation of Natural GH Axis

    Unlike exogenous HGH, CJC-1295 / Ipamorelin works through the body's own feedback loop, maintaining natural pulsatile GH release and avoiding the suppression of endogenous production.

    CJC-1295 / Ipamorelin Benefits

    CJC-1295 / Ipamorelin is used across a broad range of clinical applications driven by growth hormone optimization. Its most well-supported benefits include:

    Body Composition: Fat Loss & Muscle Preservation

    Growth hormone is one of the primary drivers of lipolysis, the breakdown and mobilization of stored fat for energy. Elevated GH and IGF-1 from CJC-1295 / Ipamorelin promote fat oxidation, particularly visceral fat, while simultaneously supporting lean muscle preservation. Most patients notice meaningful body composition improvements over a 3–6 month protocol.

    Accelerated Recovery

    IGF-1 directly supports tissue repair, accelerating recovery from training, injury, and the general wear of physical activity. CJC-1295 / Ipamorelin is widely used by athletes to shorten recovery timelines, reduce soreness, and support adaptation to training loads that would otherwise require longer rest periods.

    Sleep Quality & Deep Sleep Enhancement

    Growth hormone is secreted primarily during slow-wave (deep) sleep, and the relationship is bidirectional: GH supports sleep architecture, and deep sleep drives GH release. CJC-1295 / Ipamorelin is typically dosed before bed precisely to amplify the natural nocturnal GH pulse, with many patients reporting noticeably deeper, more restorative sleep within the first weeks of use.

    Anti-Aging & Cellular Regeneration

    GH and IGF-1 decline significantly with age, a process known as somatopause, and this decline is associated with increases in body fat, loss of muscle mass, reduced bone density, declining cognitive function, and slowed tissue repair. CJC-1295 / Ipamorelin directly addresses this decline, making it one of the most clinically meaningful anti-aging interventions available.

    Bone Density Support

    IGF-1 stimulates osteoblast activity and supports bone mineral density. Long-term use of GH secretagogues is associated with improved bone density, particularly relevant for older patients at risk of osteopenia or osteoporosis.

    Cognitive Function & Mood

    Growth hormone receptors are present throughout the brain, and GH plays a documented role in cognitive function, mood regulation, and neurological health. Many patients on CJC-1295 / Ipamorelin protocols report improvements in mental clarity, motivation, and emotional wellbeing.

    Skin & Connective Tissue Quality

    IGF-1 stimulates collagen synthesis and skin cell turnover, contributing to improved skin elasticity, texture, and thickness, a visible anti-aging benefit reported by many long-term users of GH secretagogue protocols.

    CJC-1295 / Ipamorelin Dosage & Administration

    ⚕️ Dosage is determined by your prescribing provider based on your individual health profile, hormone levels, and therapeutic goals. The following reflects available formulations at VitalRx and general clinical reference information.

    Subcutaneous Injection

    CJC-1295 / Ipamorelin is administered as a subcutaneous injection, injected just under the skin using a small insulin-style syringe, typically in the abdomen. Evening dosing before bed is standard practice, as it amplifies the natural nocturnal GH pulse that occurs during deep sleep.

    Concentration

    CJC-1295 2mg/mL + Ipamorelin 2mg/mL, 5mL vial

    Typical Dose

    100–300mcg of each peptide per injection

    Frequency

    Once daily before bed; some protocols use twice daily

    Onset

    Sleep improvements in 1–2 weeks; body composition over 3–6 months

    Protocol Phases

    1

    Initial Protocol Months 1–3

    Once-daily subcutaneous injection before bed. Provider monitors for response and tolerability before adjusting dose or frequency.

    2

    Optimization Phase Months 3–6

    Protocol may be adjusted based on response; some patients progress to twice-daily dosing or dose adjustments. IGF-1 levels may be monitored to guide titration.

    3

    Maintenance Ongoing or cycled

    Many patients use CJC-1295 / Ipamorelin on an ongoing basis as part of a long-term anti-aging or performance protocol. Your provider will advise on cycling versus continuous use based on your goals and response.

    Important Notes

    • Evening dosing before bed is standard; this aligns with the natural nocturnal GH pulse and maximizes sleep quality benefits
    • Avoid eating for 1–2 hours before and after injection; insulin elevation blunts GH release
    • Refrigerate upon receipt and use within the timeframe specified on your prescription label
    • Syringes and alcohol swabs are included with your order
    • IGF-1 blood testing is recommended to monitor protocol response and guide dose optimization
    • Do not adjust dose or frequency without consulting your provider

    CJC-1295 / Ipamorelin vs. HGH: What's the Difference?

    A common question from patients researching growth hormone optimization is how CJC-1295 / Ipamorelin compares to synthetic human growth hormone (HGH). The distinction matters clinically and practically.

    CJC-1295 / Ipamorelin

    Growth Hormone Secretagogues

    Stimulates the pituitary to produce and release your own growth hormone through two complementary pathways. Maintains natural pulsatile GH release and preserves the body's feedback regulation. Does not suppress endogenous production. Significantly more accessible, more affordable, and legally available via compounding prescription.

    Best for: Most patients seeking GH optimization, body composition improvement, recovery support, anti-aging, and sleep enhancement

    Synthetic HGH

    Exogenous Growth Hormone

    Delivers growth hormone directly, bypassing the pituitary entirely. Produces a large, non-physiological GH spike rather than a natural pulse. Suppresses endogenous GH production over time. Carries higher risk of side effects including insulin resistance, edema, and carpal tunnel syndrome. Significantly more expensive and more tightly regulated.

    Best for: Patients with documented GH deficiency who have been unresponsive to secretagogue therapy

    For the vast majority of patients seeking the benefits of elevated growth hormone (body composition, recovery, sleep, anti-aging), CJC-1295 / Ipamorelin delivers meaningful results through a safer, more physiologically appropriate, and far more accessible pathway than synthetic HGH.

    Who Is CJC-1295 / Ipamorelin For?

    CJC-1295 / Ipamorelin may be a good fit if you are:

    • Experiencing the classic signs of age-related GH decline: increased body fat, reduced muscle mass, slower recovery, declining energy, or poor sleep quality
    • An athlete or active individual looking to accelerate recovery, improve body composition, and support adaptation to training
    • Interested in a clinically-guided anti-aging protocol targeting the hormonal drivers of cellular decline
    • Looking for improved sleep quality and depth, particularly slow-wave sleep
    • Seeking a growth hormone optimization approach that works with your body's natural axis rather than replacing it
    • Considering HGH therapy but looking for a more accessible, better-tolerated, and physiologically appropriate alternative

    Not for everyone: CJC-1295 / Ipamorelin may not be appropriate for patients with active malignancy, certain metabolic conditions, or those on specific medications. Your provider will review your full health history and current hormone levels during the async consultation.

    CJC-1295 / Ipamorelin Pricing at VitalRx

    All prices below are retail. Your async provider consultation is included with every order. Syringes and alcohol swabs are included. Shipping via FedEx Standard Overnight is $15.

    CJC-1295 / Ipamorelin vial

    CJC-1295 / Ipamorelin 2mg/2mg per mL, 5mL

    Subcutaneous Injectable • Syringes Included

    $225

    per vial

    CJC-1295 2mg/mL + Ipamorelin 2mg/mL, 5mL vial. The most widely prescribed growth hormone secretagogue combination. Prescription required.

    FedEx Standard Overnight: $15.00
    Async provider visit included

    How to Get Started with CJC-1295 / Ipamorelin at VitalRx

    1

    Select Your Protocol

    Add CJC-1295 / Ipamorelin to your order. Your async provider consult is included and will cover dosing, timing, and what to expect.

    2

    Complete Your Async Consult

    Answer a brief health intake questionnaire at your own pace. No video call, no waiting room. A licensed provider reviews your submission, evaluates your hormone health history, and issues your prescription when clinically appropriate.

    3

    Receive Your Order

    Your prescription is filled by Optimal Balance Pharmacy and shipped via FedEx Standard Overnight directly to your door, with syringes and alcohol swabs included.

    Prescription required. Async provider visit included. All compounds prepared by Optimal Balance Pharmacy.

    Frequently Asked Questions About CJC-1295 / Ipamorelin

    The information provided on this page is for educational purposes only and does not constitute medical advice. All medications available through VitalRx require a valid prescription from a licensed healthcare provider. CJC-1295 / Ipamorelin is not appropriate for everyone, including patients with active malignancy or certain metabolic conditions. Results vary based on individual health status, hormone levels, dosing, and adherence to protocol. This content has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new treatment.